These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 892335)

  • 21. On the pathological modification of serum high density lipoproteins in liver diseases. An alteration in the binding mode of indocyanine-green with human serum proteins.
    Tanaka N; Kanai K; Oda T
    Clin Chim Acta; 1973 Dec; 49(3):333-40. PubMed ID: 4359888
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
    Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
    Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum glycoprotein concentrations in chronic liver diseases].
    Fehér J; Jakab L; Szilvási I
    Orv Hetil; 1973; 114(29):1737-41. PubMed ID: 4721855
    [No Abstract]   [Full Text] [Related]  

  • 24. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.
    Marshall JS; Green AM; Pensky J; Williams S; Zinn A; Carlson DM
    J Clin Invest; 1974 Sep; 54(3):555-62. PubMed ID: 4137057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum protein electrophoresis in healthy subjects and patients with liver disease.
    Zuberi SJ; Lodi TZ
    J Pak Med Assoc; 1978 Oct; 28(10):140-1. PubMed ID: 101684
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum beta 2-microglobulin in chronic liver diseases.
    Nakamura S; Takezawa Y; Maeda T
    Tohoku J Exp Med; 1981 Jun; 134(2):221-2. PubMed ID: 6171912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans.
    Teirlynck O; Belpaire FM; Andreasen F
    Eur J Clin Pharmacol; 1982; 21(5):427-31. PubMed ID: 7075647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.
    Takata Y; Yoshizumi T; Ito Y; Kikuchi M; Ueno M; Tsukashima A; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1992; 42(5):475-9. PubMed ID: 1606993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases.
    Morelli A; Vedovelli A; Fiorucci S; Angelini GP; Fini C; Palmerini CA; Floridi A
    Clin Chim Acta; 1985 May; 148(2):87-95. PubMed ID: 3888456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease.
    Yoshida K; Hirayama C
    Clin Chim Acta; 1980 Feb; 101(2-3):235-40. PubMed ID: 6244122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis.
    Zöhrens G; Armbrust T; Pirzer U; Meyer zum Büschenfelde KH; Ramadori G
    Hepatology; 1993 Oct; 18(4):798-802. PubMed ID: 8104856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.
    Colakoğlu O; Taşkiran B; Colakoğlu G; Kizildağ S; Ari Ozcan F; Unsal B
    Turk J Gastroenterol; 2007 Dec; 18(4):245-9. PubMed ID: 18080921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.
    Barry M; Keeling PW; Weir D; Feely J
    Clin Pharmacol Ther; 1990 Mar; 47(3):366-70. PubMed ID: 2311337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
    Kawasaki H; Murawaki Y; Hirayama C
    Am J Gastroenterol; 1986 Jan; 81(1):67-70. PubMed ID: 3510529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
    Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
    Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ; Liaw YF
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic liver diseases with normal blood protein levels].
    Buzzelli G; Gallerini L; Guarducci AM; Laffi G; Mazzanti R; Smorlesi C; Gentilini P
    Recenti Prog Med; 1977 Nov; 63(5):497-526. PubMed ID: 75556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.